{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:28:39Z","timestamp":1769632119182,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Worldwide despite the availability of antiretroviral therapy, human immunodeficiency virus\/acquired immunodeficiency syndrome still causes morbidity and mortality among patients. In Sub-Saharan Africa, human immunodeficiency virus\/acquired immunodeficiency syndrome remains a major public health concern. The aim of this study was to identify the causes of morbidity and mortality in the modern antiretroviral therapy era in Sub-Saharan Africa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a systematic review according to the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. We searched relevant studies from 3 databases which are Google Scholar, PubMed, and CINAHL. Two review authors independently screened titles, abstracts, and full-text articles in duplicate, extracted data, and assessed bias. Discrepancies were resolved by discussion or arbitration of a third review author. R software version 3.6.2 was used to analyze the data. Maximum values were used in order to show which disease was mostly spread out by looking at the highest prevalence reported. This systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 409 articles were obtained from the database search, finally 12 articles met the inclusion criteria and were eligible for data extraction. Among them, 3 were conducted in Nigeria, 2 were conducted in Uganda, 3 were conducted in South Africa, 1 in Gabon, 1 in Ethiopia, 1 in Ghana, and 1 in Burkina Faso. In most of the included studies, tuberculosis was the leading cause of hospitalization which accounted for between 18% and 40.7% and it was also the leading cause of death and accounted for between 16% and 44.3%, except in 1 which reported anemia as the leading cause of hospitalization and in 2 which reported wasting syndrome and meningitis respectively as the leading causes of death. Opportunistic malignancies accounted between for 1.8% to 5% of hospitalization and 1.2% to 9.8% of deaths.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Tuberculosis is the commonest cause of hospitalization and death in Sub-Saharan Africa, but it is always followed by other infectious disease and other non-AIDS related causes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027342","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T12:18:24Z","timestamp":1635509904000},"page":"e27342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Cause of hospitalization and death in the antiretroviral era in Sub-Saharan Africa published 2008\u20132018"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-0236","authenticated-orcid":false,"given":"Manimani Riziki","family":"Ghislain","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloire-Aime Aganze","family":"Mushebenge","sequence":"additional","affiliation":[{"name":"Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nombulelo","family":"Magula","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.11604\/pamj.2015.20.63.4865","article-title":"Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya","volume":"20","author":"Muhula","year":"2015","journal-title":"Pan Afr Med J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12879-017-2473-y","article-title":"Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil-associated factors and causes of death","volume":"17","author":"da Silva Escada","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/QAD.0b013e32833a2507","article-title":"Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa","volume":"24","author":"Komati","year":"2010","journal-title":"AIDS (London, England)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ije\/27.4.698","article-title":"Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda","volume":"27","author":"Okongo","year":"1998","journal-title":"Int J Epidemiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"R11-20250504","first-page":"01","article-title":"Prevalence of anaemia before and after the initiation of antiretroviral therapy at ART centre of Hawassa University Referral Hospital, Hawassa, South Ethiopia","volume":"3","author":"Daka","year":"2013","journal-title":"Sch J Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"c285","DOI":"10.1159\/000322278","article-title":"Clinical characteristics of kidney disease in Japanese HIV-infected patients","volume":"118","author":"Yanagisawa","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijid.2017.05.012","article-title":"Performance of the antiretroviral treatment program in Ethiopia, 2005-2015: strengths and weaknesses toward ending AIDS","volume":"60","author":"Assefa","year":"2017","journal-title":"Int J Infect Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833a0918","article-title":"Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D Study","volume":"24","year":"2010","journal-title":"AIDS"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3855\/jidc.1096","article-title":"Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians","volume":"5","author":"Agaba","year":"2011","journal-title":"J Infect Develop Count"},{"key":"R19-20250504","article-title":"Morbidity and mortality patterns of hospitalised adult HIV\/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, Northern Nigeria","volume":"2012","author":"Ogoina","year":"2012","journal-title":"AIDS Res Treat"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1995-7645(10)60054-5","article-title":"HIV\/AIDS related mortality among adult medical patients in a tertiary health institution in South\u2013South, Nigeria","volume":"3","author":"Gyuse","year":"2010","journal-title":"Asian Pac J Trop Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4314\/ahs.v13i4.17","article-title":"Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda","volume":"13","author":"Namutebi","year":"2013","journal-title":"Afr Health Sci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0b013e3182303716","article-title":"Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda","volume":"58","author":"Moore","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.trstmh.2008.10.001","article-title":"Mortality and loss to follow-up among HAART initiators in rural South Africa","volume":"103","author":"MacPherson","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R24-20250504","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002269","article-title":"HIV-related medical admissions to a South African district hospital remain frequent despite effective antiretroviral therapy scale-up","volume":"94","author":"Meintjes","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"548","DOI":"10.20452\/pamw.486","article-title":"Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital","volume":"118","author":"Mzileni","year":"2008","journal-title":"Pol Arch Med Wewn"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4269\/ajtmh.12-0780","article-title":"Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study","volume":"90","author":"Okome-Nkoumou","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s13104-018-3707-9","article-title":"Spectrum of opportunistic infections and associated factors among people living with HIV\/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study","volume":"11","author":"Solomon","year":"2018","journal-title":"BMC Res Notes"},{"key":"R28-20250504","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2017.27.48.8917","article-title":"Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital","volume":"27","author":"Saavedra","year":"2017","journal-title":"Pan Afr Med J"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/09540121.2011.630353","article-title":"Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study","volume":"24","author":"Kouanda","year":"2012","journal-title":"AIDS Care"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13550280290049723","article-title":"Central nervous system infections in individuals with HIV-1 infection","volume":"8","author":"Mamidi","year":"2002","journal-title":"J Neurovirol"},{"key":"R31-20250504","article-title":"Mortality and its predictors among HIV infected patients taking antiretroviral treatment in ethiopia: a systematic review","volume":"2017","author":"Biset Ayalew","year":"2017","journal-title":"AIDS Res Treat"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3018(15)00137-X","article-title":"Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis","volume":"2","author":"Ford","year":"2015","journal-title":"Lancet HIV"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"issue":"(suppl_2)","key":"R34-20250504","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cix1141","article-title":"Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial","volume":"66","author":"Post","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12865-018-0278-4","article-title":"Prevalence and associated factors of treatment failure among HIV\/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia","volume":"19","author":"Ayele","year":"2018","journal-title":"BMC Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2471\/BLT.08.058982","article-title":"Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa","volume":"87","author":"Herbst","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"e0170893","DOI":"10.1371\/journal.pone.0170893","article-title":"Adherence to antiretroviral therapy (ART) in Yaound\u00e9-Cameroon: association with opportunistic infections, depression, ART regimen and side effects","volume":"12","author":"Fonsah","year":"2017","journal-title":"PLoS One"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12879-015-0927-7","article-title":"Trends in prevalence of selected opportunistic infections associated with HIV\/AIDS in Uganda","volume":"15","author":"Rubaihayo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R39-20250504","article-title":"Predictors of mortality among adult antiretroviral therapy users in south eastern Ethiopia: retrospective cohort study","volume":"2015","author":"Setegn","year":"2015","journal-title":"AIDS Res Treat"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"e20010","DOI":"10.1371\/journal.pone.0020010","article-title":"Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana","volume":"6","author":"Steele","year":"2011","journal-title":"PLoS One"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3201\/eid1502.080942","article-title":"Causes of death in HIV-infected persons who have tuberculosis, Thailand","volume":"15","author":"Cain","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bmj.308.6943.1531","article-title":"Contribution of tuberculosis to slim disease in Africa","volume":"308","author":"Lucas","year":"1994","journal-title":"BMJ"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"e0127024","DOI":"10.1371\/journal.pone.0127024","article-title":"Successful tuberculosis treatment outcomes among HIV\/TB coinfected patients down-referred from a district hospital to primary health clinics in rural South Africa","volume":"10","author":"Jacobson","year":"2015","journal-title":"PLoS One"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0b013e3181b32baf","article-title":"Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia","volume":"53","author":"Koethe","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/383031","article-title":"Anaemia in HIV infection: clinical impact and evidence-based management strategies","volume":"38","author":"Volberding","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5455\/jihp.20130122042052","article-title":"Prevalence of anemia and associated risk factors among pregnant women attending antenatal care in Azezo Health Center Gondar town, Northwest Ethiopia","volume":"1","author":"Alem","year":"2013","journal-title":"J Interdisc Histopathol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/asheducation-2013.1.377","article-title":"Pathogenesis and clinical implications of HIV-related anemia in 2013","volume":"2013","author":"Redig","year":"2013","journal-title":"Hematol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s002770050340","article-title":"Pathogenesis and pathophysiology of anemia in HIV infection","volume":"75","author":"Kreuzer","year":"1997","journal-title":"Ann Hematol"},{"key":"R51-20250504","first-page":"01","article-title":"Resolution of anemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa","volume":"14","author":"Kerkhoff","year":"2014","journal-title":"BMC Inect Dis"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0399-077X(04)00146-5","article-title":"Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)","volume":"34","author":"Lewden","year":"2004","journal-title":"Med Mal Infect"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00042560-200008010-00013","article-title":"Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study","volume":"24","author":"Hung","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.2012.11-0691","article-title":"Promoting good clinical laboratory practices and laboratory accreditation to support clinical trials in sub-Saharan Africa","volume":"86","author":"Guindo","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0b013e328360a5a1","article-title":"Immune reconstitution inflammatory syndrome associated with kaposi sarcoma: higher incidence and mortality in Africa than in the UK","volume":"27","author":"Letang","year":"2013","journal-title":"AIDS"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:10:49Z","timestamp":1746331849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027342"}},"subtitle":["A systematic review"],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":50,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027342","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"2020-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}